NCT07314086 is a clinical trial in Gynecomastia, sponsored by First Affiliated Hospital of Harbin Medical University.

Who is sponsoring NCT07314086?

NCT07314086 is sponsored by First Affiliated Hospital of Harbin Medical University.

What condition does NCT07314086 study?

NCT07314086 studies Gynecomastia.

Is NCT07314086 still recruiting?

NCT07314086 is currently active, enrolled. Last updated 2 January 2026.

Last reviewed 2026-01-02 · How we verify

NCT07314086

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Clinical Effectiveness Study of Total Laparoscopic Subcutaneous Gland Resection Combined With Nipple-Areola Complex Lift in the Management of Moderate to Severe Gynecomastia in Males

Active, enrolled Last updated 2 January 2026

What this trial tests

trial in Gynecomastia in 200 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 September 2021

Primary endpoint
1 January 2027

1 June 2027

Quick facts

Lead sponsor	First Affiliated Hospital of Harbin Medical University
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 September 2021
Primary completion	1 January 2027
Estimated completion	1 June 2027
Sites	1 location across China

Conditions studied

Gynecomastia — all drugs for Gynecomastia →

Sponsor

First Affiliated Hospital of Harbin Medical University

Who can join

Adults 18 to 65, male only, with Gynecomastia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate and compare the treatment outcomes of total laparoscopic subcutaneous gland resection combined with nipple-areola complex (NAC) lift surgery against those of isolated laparoscopic surgery in the management of moderate to severe gynecomastia (GYN) in males.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other First Affiliated Hospital of Harbin Medical University trials

Trials by the same sponsor.

NCT07020195 — QFR-Based Functional SYNTAX Score System in Optimizing Revascularization Strategy for Multivessel Disease · NA · not yet recruiting
NCT06995456 — Multivariate Analysis and Prediction of Hypertensive Disorder Complicating Pregnancy and Its Related Mechanism · not yet recruiting
NCT06975592 — Study on the Mechanism of Multi-group Analysis of the Influence of Depression on Common Cardiovascular Diseases · not yet recruiting
NCT07087093 — Effects of Ketone Esters on Circulating Senescent T Lymphocytes (T Cells) and Inflammation Levels in the Elderly · NA · recruiting
NCT06565845 — Analysis of Various Treatment Methods of Granulomatous Lobular Mastitis · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07314086 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital of Harbin Medical University
Last refreshed: 2 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07314086.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing